Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 19, 2015
Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapyElizabeth Dudnik, Tali Siegal, Leor Zach, et al.The Cochrane Database of Systematic Reviews|April 14, 2016
Interventions for the management of fatigue in adults with a primary brain tumourJulia Day, Shlomit Yust-Katz, David Cachia, et al.Cytotherapy|November 2, 2011
Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stressShlomit Yust-Katz, Yonit Fisher-Shoval, Yael Barhum, et al.Journal of Neurosurgery|July 4, 2025
Let the light in: influence of fluorescence-guided resection with 5-aminolevulinic acid on surgical outcomes, extent of resection, and survival in subventricular zone glioblastomaYosef Laviv, Paz Lev, Sapir Lev, et al.Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|November 3, 2023
Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme PhenotypeYosef Laviv, Eilat Sapirstein, Andrew A Kanner, et al.The Israel Medical Association Journal : IMAJ|January 14, 2020
Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer: The Davidoff Cancer Center ExperienceElizabeth Dudnik, Aaron M Allen, Natalia Michaeli, et al.Journal of Molecular Neuroscience : MN|May 29, 2012
Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MSYonit Fisher-Shoval, Yael Barhum, Ofer Sadan, et al.Journal of Neuro-Oncology|August 30, 2014
Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institutionJacob J Mandel, Shlomit Yust-Katz, David Cachia, et al.Journal of Neuro-Oncology|March 12, 2025
Long-term impact of bevacizumab for the treatment of brain radiation necrosisHila Nobel, Jonathan Ofer, Sara Faye Borenstein, et al.Neuro-Oncology Advances|October 21, 2024
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumorDror Limon, Alexandra Amiel, Shaked Even Haim, et al.Pageof 8